Mechanisms of Transcriptional Regulation in Disease: From Chromatin Dynamics to Therapeutic Innovation

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cell and Gene Therapy".

Deadline for manuscript submissions: 30 November 2026

Special Issue Editors


E-Mail Website1 Website2
Guest Editor
Cancer, Infection and Therapeutics Research Group, School of Applied and Health Science, College of Health and Life Science, London South Bank University, London, UK
Interests: epigenetic regulation, non -coding genome, histone acetylation; chromosomal translocation; BET inhibitors; regulatory genomics; multiple myeloma
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Cancer, Infection and Therapeutics Research Group, School of Applied and Health Science, College of Health and Life Science, London South Bank University, London, UK
Interests: gene expression; transcriptional regulation; non-coding genome; epigenetics; haematological malignancies; therapeutic targets

Special Issue Information

Dear Colleagues,

Gene transcription is a core biological process that determines cellular identity, function, and responsiveness to environmental signals. In the context of human disease, disruptions in transcriptional regulation can result in abnormal cellular behaviour and pathological outcomes. Advances in molecular biology, multi-omics technologies, and precision gene editing tools have revealed that transcription is a highly dynamic and multidimensional process. It involves intricate interactions among genetic and epigenetic regulators, nuclear complexes, chromatin architecture and supranuclear domains. A deeper understanding of these regulatory layers has opened new possibilities for therapeutic intervention. Epigenetic therapies—such as histone deacetylase (HDAC), bromodomain and extra-terminal domain (BET) and cyclin-dependent kinase (CDK) inhibitors—are emerging as promising strategies to restore normal transcriptional activity by modulating chromatin structure and accessibility. 

This Special Issue aims to highlight pioneering research on the mechanisms by which transcriptional regulation influences human disease and how these pathways can be therapeutically targeted. Featured topics will include: 

  • Epigenetically controlled genes and their therapeutic relevance;
  • The role of the non-coding genome in transcriptional regulation;
  • Nuclear architecture and enhancer dynamics in disease contexts;
  • Mechanistic insights into transcriptional inhibitors;
  • Transcription factor networks and chromatin regulators in disease establishment and progression;
  • Innovative tools, strategies, and databases for transcriptional research;
  • Development of novel drugs, inhibitors, and degraders targeting the transcriptional machinery.

Dr. Valentina Caputo
Dr. Joana R. Costa
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • transcription regulation
  • epigenomics
  • multi-omics
  • non-coding genome
  • chromatin architecture/dynamics
  • enhancers

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop